Author:
Pieterman Elsbet J.,Princen Hans M. G.,Jarke Annica,Nilsson Ralf,Cavallin Anders,Bergenholm Linnéa,Henricsson Marcus,Gopaul V. Sashi,Agrawal Rahul,Nissen Steven E.,Hurt-Camejo Eva
Abstract
We investigated the effects of chronic oral administration of mineral oil, versus corn oil as control, on intestinal permeability, inflammatory markers, and plasma lipids in APOE*3-Leiden.CETP mice. Mice received mineral oil or corn oil 15 or 30 μL/mouse/day for 16 weeks (15 mice/group). Intestinal permeability was increased with mineral versus corn oil 30 µL/day, shown by increased mean plasma FITC-dextran concentrations 2 h post-administration (11 weeks: 1.5 versus 1.1 μg/ml, p = 0.02; 15 weeks: 1.7 versus 1.3 μg/ml, p = 0.08). Mean plasma lipopolysaccharide-binding protein levels were raised with mineral versus corn oil 30 µL/day (12 weeks: 5.8 versus 4.4 μg/ml, p = 0.03; 16 weeks: 5.8 versus 4.5 μg/ml, p = 0.09), indicating increased intestinal bacterial endotoxin absorption and potential pro-inflammatory effects. Plasma cholesterol and triglyceride concentrations were decreased with mineral oil, without affecting liver lipids among treated groups. Fecal neutral sterol measurements indicated increased fecal cholesterol excretion with mineral oil 30 µL/day (+16%; p = 0.04). Chronic oral administration of mineral oil in APOE*3-Leiden.CETP mice increased intestinal permeability, with potential pro-inflammatory effects, and decreased plasma cholesterol and triglyceride levels. Our findings may raise concerns about the use of mineral oil as a placebo in clinical studies.
Subject
Pharmacology (medical),Pharmacology
Reference49 articles.
1. PCSK9 Inhibition Fails to Alter Hepatic LDLR, Circulating Cholesterol, and Atherosclerosis in the Absence of ApoE;Ason;J. Lipid Res.,2014
2. Efficacy and Safety of Eicosapentaenoic Acid Ethyl Ester (AMR101) Therapy in Statin-Treated Patients with Persistent High Triglycerides (From the ANCHOR Study);Ballantyne;Am. J. Cardiol.,2012
3. Eicosapentaenoic Acid Ethyl Ester (AMR101) Therapy in Patients with Very High Triglyceride Levels (From the Multi-center, plAcebo-Controlled, Randomized, Double-blINd, 12-week Study with an Open-Label Extension [MARINE] Trial);Bays;Am. J. Cardiol.,2011
4. Cardiovascular Risk Reduction with Icosapent Ethyl for Hypertriglyceridemia;Bhatt;N. Engl. J. Med.,2019
5. A Rapid Method of Total Lipid Extraction and Purification;Bligh;Can. J. Biochem. Physiol.,1959
Cited by
2 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献